Personalized cancer care: DNA profiling guides patients to best trials

NCT ID NCT02806388

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study analyzes the DNA of solid tumors from 5,500 cancer patients to find genetic changes that could be targeted by specific treatments. The goal is to use this molecular profile to match patients with appropriate clinical trials. Participants must have a confirmed solid tumor diagnosis and be able to provide a tissue sample.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors choose better treatments for cancer patients by matching them to the right clinical trials based on their tumor's genetic profile.

What could go wrong

This is an observational study, not a treatment trial. It may not directly benefit participants, and finding a matching trial does not guarantee the treatment will work.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Cancer Centre, Singapore

    RECRUITING

    Singapore, Singapore